Ceritinib Noxalk, Natco, Pack Of 30 Capsules Medicine Raw Materials

Ceritinib noxalk capsules are a targeted therapy for patients with non small cell lung cancer that harbor an alk gene rearrangement. These are indicated for the treatment of patients with metastatic non small cell lung cancer whose tumors have an anaplastic lymphoma kinase (alk) gene rearrangement, as detected by an fda approved test. These are taken orally once daily. Side effects of capsules include diarrhea, nausea, vomiting, abdominal pain, fatigue, constipation, decreased appetite, weight loss, and hyperglycemia. Please contact your physician if you experience any of these side effects. These are a chemotherapy medication that works by killing cancer cells and slowing the growth of cancer cells. It is used to treat advanced thyroid cancer.